Cargando…

Safety and efficacy of a probiotic-containing infant formula supplemented with 2’-fucosyllactose: a double-blind randomized controlled trial

BACKGROUND: Human milk oligosaccharides (HMOs) have important and diverse biological functions in early life. This study tested the safety and efficacy of a starter infant formula containing Limosilactobacillus (L.) reuteri DSM 17938 and supplemented with 2’-fucosyllactose (2’FL). METHODS: Healthy i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alliet, Philippe, Vandenplas, Yvan, Roggero, Paola, Jespers, Sabine N. J., Peeters, Stefaan, Stalens, Jean-Philippe, Kortman, Guus A. M., Amico, Mailis, Berger, Bernard, Sprenger, Norbert, Cercamondi, Colin I., Corsello, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862345/ https://www.ncbi.nlm.nih.gov/pubmed/35193609 http://dx.doi.org/10.1186/s12937-022-00764-2

Ejemplares similares

Randomised controlled trial demonstrates that fermented infant formula with short‐chain galacto‐oligosaccharides and long‐chain fructo‐oligosaccharides reduces the incidence of infantile colic
por: Vandenplas, Yvan, et al.
Publicado: (2017)

Effects of Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity: A Randomized Multicenter Trial
por: Puccio, Giuseppe, et al.
Publicado: (2017)

Human Milk Oligosaccharides: 2′-Fucosyllactose (2′-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula
por: Vandenplas, Yvan, et al.
Publicado: (2018)

Term infant formula supplemented with milk-derived oligosaccharides shifts the gut microbiota closer to that of human milk-fed infants and improves intestinal immune defense: a randomized controlled trial
por: Estorninos, Elvira, et al.
Publicado: (2021)

Limosilactobacillus reuteri DSM 17938-Containing Infant Formulas and the Associations with Gastrointestinal Tolerance: A Cross-Sectional Observational Study
por: Lavalle, Luca, et al.
Publicado: (2023)

Determination of 2′-Fucosyllactose and Lacto-N-neotetraose in Infant Formula
por: Austin, Sean, et al.
Publicado: (2018)

Efficacy of the Probiotic Probiotical Confirmed in Acute Gastroenteritis
por: Kluijfhout, Sandra, et al.
Publicado: (2020)

Probiotics and Prebiotics in Pediatrics: What Is New?
por: Vandenplas, Yvan, et al.
Publicado: (2019)

An infant formula with large, milk phospholipid–coated lipid droplets containing a mixture of dairy and vegetable lipids supports adequate growth and is well tolerated in healthy, term infants
por: Breij, Laura M, et al.
Publicado: (2019)

Probiotics in Pediatrics. A Review and Practical Guide
por: Depoorter, Leontien, et al.
Publicado: (2021)

Efficacy and Tolerance of a New Anti-Regurgitation Formula
por: Dupont, Christophe, et al.
Publicado: (2016)

The Role of Two Human Milk Oligosaccharides, 2′-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition
por: Hegar, Badriul, et al.
Publicado: (2019)

Screening of Bifidobacteria with Probiotic Potential from Healthy Infant Feces by Using 2′-Fucosyllactose
por: Zhang, Gongsheng, et al.
Publicado: (2023)

Review of the Clinical Experiences of Feeding Infants Formula Containing the Human Milk Oligosaccharide 2′-Fucosyllactose
por: Reverri, Elizabeth J., et al.
Publicado: (2018)

A Comparison of the In Vitro Effects of 2’Fucosyllactose and Lactose on the Composition and Activity of Gut Microbiota from Infants and Toddlers
por: Van den Abbeele, Pieter, et al.
Publicado: (2021)

Probiotics in the Prevention and Treatment of Necrotizing Enterocolitis
por: Seghesio, Eleonora, et al.
Publicado: (2021)

The Link between Different Types of Prebiotics in Infant Formula and Infection Rates: A Review
por: Cool, Roxane, et al.
Publicado: (2023)

Construction of Escherichia coli strains with chromosomally integrated expression cassettes for the synthesis of 2(′)-fucosyllactose
por: Baumgärtner, Florian, et al.
Publicado: (2013)

The Magnesium-Rich Formula for Functional Constipation in Infants: a Randomized Comparator-Controlled Study
por: Benninga, Marc A., et al.
Publicado: (2019)

Infant Formula With a Specific Blend of Five Human Milk Oligosaccharides Drives the Gut Microbiota Development and Improves Gut Maturation Markers: A Randomized Controlled Trial
por: Bosheva, Miroslava, et al.
Publicado: (2022)

Health Effects of Infant Formula Supplemented with Probiotics or Synbiotics in Infants and Toddlers: Systematic Review with Network Meta-Analysis
por: Indrio, Flavia, et al.
Publicado: (2022)

Nutritional Status of Children Hospitalized for Parapneumonic Effusion
por: Huysentruyt, Koen, et al.
Publicado: (2014)

Infant feeding practice and gastrointestinal tolerance: a real-world, multi-country, cross-sectional observational study
por: Lavalle, Luca, et al.
Publicado: (2022)

Safety and adequacy of a semi-elemental formula for children with gastro-intestinal disease
por: Vandenplas, Yvan, et al.
Publicado: (2009)

Multi‐level metabolic engineering of Escherichia coli for high‐titer biosynthesis of 2′‐fucosyllactose and 3‐fucosyllactose
por: Li, Mengli, et al.
Publicado: (2022)

Effects of addition of 2-fucosyllactose to infant formula on growth and specific pathways of utilization by Bifidobacterium in healthy term infants
por: Wallingford, John C., et al.
Publicado: (2022)

Plant-Based Formulas and Liquid Feedings for Infants and Toddlers
por: Vandenplas, Yvan, et al.
Publicado: (2021)

Reply to von Bünau et al. Comment on “Depoorter, L.; Vandenplas, Y. Probiotics in Pediatrics. A Review and Practical Guide. Nutrients 2021, 13, 2176”
por: Vandenplas, Yvan, et al.
Publicado: (2022)

In Vitro Probiotic Modulation of the Intestinal Microbiota and 2′Fucosyllactose Consumption in Fecal Cultures from Infants at Two Months of Age
por: Nogacka, Alicja M., et al.
Publicado: (2022)

Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics
por: Berger, Bernard, et al.
Publicado: (2020)

An Observational Real-Life Study with a New Infant Formula in Infants with Functional Gastro-Intestinal Disorders
por: Vandenplas, Yvan, et al.
Publicado: (2021)

Safety and tolerance of a new extensively hydrolyzed rice protein-based formula in the management of infants with cow’s milk protein allergy
por: Vandenplas, Yvan, et al.
Publicado: (2014)

An extensively hydrolysed rice protein-based formula in the management of infants with cow's milk protein allergy: preliminary results after 1 month
por: Vandenplas, Yvan, et al.
Publicado: (2014)

Strain-specific strategies of 2′-fucosyllactose, 3-fucosyllactose, and difucosyllactose assimilation by Bifidobacterium longum subsp. infantis Bi-26 and ATCC 15697
por: Zabel, Bryan E., et al.
Publicado: (2020)

Growth and Tolerance Assessment of a Lutein-fortified Infant Formula
por: Kon, Igor Ya., et al.
Publicado: (2014)

Safety of a New Synbiotic Starter Formula
por: Vandenplas, Yvan, et al.
Publicado: (2017)

Effectiveness and Tolerance of a Locust Bean Gum-Thickened Formula: A Real-Life Study
por: Tounian, Patrick, et al.
Publicado: (2020)

Multiple functional gastrointestinal disorders are frequent in formula‐fed infants and decrease their quality of life
por: Bellaiche, Marc, et al.
Publicado: (2018)

2′-Fucosyllactose Is Well Tolerated in a 100% Whey, Partially Hydrolyzed Infant Formula With Bifidobacterium lactis: A Randomized Controlled Trial
por: Storm, Heidi M., et al.
Publicado: (2019)

Influence of 2′-Fucosyllactose on the Microbiota Composition and Metabolic Activity of Fecal Cultures from Breastfed and Formula-Fed Infants at Two Months of Age
por: Nogacka, Alicja M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7v8k30irn04o1223qucj7q1nj6